SA
Supriya Amit Kumar Singh
About Supriya Amit Kumar Singh
Data last updated:
Supriya Amit Kumar Singh is a Director at Syntel India Pharmaceutical Private Limited (since 2021). The company operates in Pharma. Syntel India Pharmaceutical Private Limited reported revenue of ₹78.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Oct 2021 | 2017 | ₹78.3 Lakh (FY 2025) | Active |
Board colleagues of Supriya Amit Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amitkumar Rajkumar Singh | 07904008 | Syntel India Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Supriya Amit Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Supriya Amit Kumar Singh
Supriya Amit Kumar Singh currently holds 1 directorship: Syntel India Pharmaceutical Private Limited (Director, since 30 Oct 2021, revenue ₹78.3 Lakh (FY 2025)).
Supriya Amit Kumar Singh was first appointed on 30 Oct 2021 as Director at Syntel India Pharmaceutical Private Limited.
The current boards of Supriya Amit Kumar Singh's companies include Amitkumar Rajkumar Singh (Syntel India Pharmaceutical Private Limited).